These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 27402995)

  • 1. Drug-Induced QT Interval Prolongation in Children: Are the Kids Alright?
    Tisdale JE
    Can J Hosp Pharm; 2016; 69(3):183-4. PubMed ID: 27402995
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacogenetics of Drug-Induced QT Interval Prolongation: An Update.
    Niemeijer MN; van den Berg ME; Eijgelsheim M; Rijnbeek PR; Stricker BH
    Drug Saf; 2015 Oct; 38(10):855-67. PubMed ID: 26108299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Refining detection of drug-induced proarrhythmia: QT interval and TRIaD.
    Shah RR; Hondeghem LM
    Heart Rhythm; 2005 Jul; 2(7):758-72. PubMed ID: 15992736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Drug-induced QT interval prolongation: do we know the risks?].
    Villamañán E; Armada E; Ruano M
    Med Clin (Barc); 2015 Mar; 144(6):269-74. PubMed ID: 24656122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of probucol, a typical hERG expression inhibitor, on in vivo QT interval prolongation in conscious dogs.
    Nogawa H; Kawai T; Yajima M; Miura M; Ogawa T; Murakami K
    Eur J Pharmacol; 2013 Nov; 720(1-3):29-37. PubMed ID: 24211675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-induced QT Interval Prolongation in the Intensive Care Unit.
    Etchegoyen CV; Keller GA; Mrad S; Cheng S; Di Girolamo G
    Curr Clin Pharmacol; 2017; 12(4):210-222. PubMed ID: 29473523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Common Genetic Variant Risk Score Is Associated With Drug-Induced QT Prolongation and Torsade de Pointes Risk: A Pilot Study.
    Strauss DG; Vicente J; Johannesen L; Blinova K; Mason JW; Weeke P; Behr ER; Roden DM; Woosley R; Kosova G; Rosenberg MA; Newton-Cheh C
    Circulation; 2017 Apr; 135(14):1300-1310. PubMed ID: 28213480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. QT interval prolongation and the risk of torsades de pointes: essentials for clinicians.
    Trinkley KE; Page RL; Lien H; Yamanouye K; Tisdale JE
    Curr Med Res Opin; 2013 Dec; 29(12):1719-26. PubMed ID: 24020938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modelling of drug-induced QT-interval prolongation: estimation approaches and translational opportunities.
    Marostica E; Van Ammel K; Teisman A; Boussery K; Van Bocxlaer J; De Ridder F; Gallacher D; Vermeulen A
    J Pharmacokinet Pharmacodyn; 2015 Dec; 42(6):659-79. PubMed ID: 26259721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical significance of QT prolongation associated with tamoxifen: A review of the literature.
    Fung K; Imeson J; Cusano F
    J Oncol Pharm Pract; 2018 Oct; 24(7):525-530. PubMed ID: 28728494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sevoflurane causes greater QTc interval prolongation in elderly patients than in younger patients.
    Nakao S; Hatano K; Sumi C; Masuzawa M; Sakamoto S; Ikeda S; Shingu K
    Anesth Analg; 2010 Mar; 110(3):775-9. PubMed ID: 20185656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beat-by-beat QT interval variability, but not QT prolongation per se, predicts drug-induced torsades de pointes in the anaesthetised methoxamine-sensitized rabbit.
    Jacobson I; Carlsson L; Duker G
    J Pharmacol Toxicol Methods; 2011; 63(1):40-6. PubMed ID: 20451633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic-pharmacodynamic modeling in the data analysis and interpretation of drug-induced QT/QTc prolongation.
    Piotrovsky V
    AAPS J; 2005 Oct; 7(3):E609-24. PubMed ID: 16353940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Halothane-anaesthetized, closed-chest, guinea-pig model for assessment of drug-induced QT-interval prolongation.
    Sakaguchi Y; Takahara A; Nakamura Y; Akie Y; Sugiyama A
    Basic Clin Pharmacol Toxicol; 2009 Jan; 104(1):43-8. PubMed ID: 18699795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. QT interval prolongation in hospitalized patients on cardiology wards: a prospective observational study.
    Khan Q; Ismail M; Haider I; Haq IU; Noor S
    Eur J Clin Pharmacol; 2017 Nov; 73(11):1511-1518. PubMed ID: 28803378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the QT interval response during sinus and paced rhythm in conscious and anesthetized beagle dogs.
    Ollerstam A; Visser SA; Duker G; Forsberg T; Persson AH; Nilsson LB; Björkman JA; Gabrielsson J; Al-Saffar A
    J Pharmacol Toxicol Methods; 2007; 56(2):131-44. PubMed ID: 17689270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of drug label information on QT interval prolongation.
    Warnier MJ; Holtkamp FA; Rutten FH; Hoes AW; de Boer A; Mol PG; De Bruin ML
    Int J Risk Saf Med; 2014; 26(2):89-98. PubMed ID: 24902506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-induced QT-interval prolongation: considerations for clinicians.
    Li EC; Esterly JS; Pohl S; Scott SD; McBride BF
    Pharmacotherapy; 2010 Jul; 30(7):684-701. PubMed ID: 20575633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. QT interval prolongation and arrhythmia: an unbreakable connection?
    Anderson ME
    J Intern Med; 2006 Jan; 259(1):81-90. PubMed ID: 16336516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statistical characterization of QT prolongation.
    Schall R; Ring A
    J Biopharm Stat; 2010 May; 20(3):543-62. PubMed ID: 20358435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.